NOVAVAX INC - FORM 10-Q - EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS - May 10, 2011

Attached files

file filename
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) OR 15D-14(E - NOVAVAX INCv221327_ex31-1.htm
EX-10.2 - LICENSE AGREEMENT, ENTERED IN FEBRUARY 25, 2011, EFFECTIVE AS OF DECEMBER 9, 20 - NOVAVAX INCv221327_ex10-2.htm
EX-10.1 - CONTRACT, EFFECTIVE AS OF FEBRUARY 24, 2011, BETWEEN THE COMPANY AND HHS/OS/ASP - NOVAVAX INCv221327_ex10-1.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS - NOVAVAX INCv221327_ex32-2.htm
EX-10.3 - GUIDELINES ON SIGNIFICANT CORPORATE GOVERNANCE ISSUES EFFECTIVE AS OF JANUARY 1 - NOVAVAX INCv221327_ex10-3.htm
10-Q - QUARTERLY REPORT - NOVAVAX INCv221327_10q.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) OR 15D-14(E - NOVAVAX INCv221327_ex31-2.htm
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT
TO 18 UNITED STATES C. §1350
(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

In connection with the Quarterly Report of Novavax, Inc. (the “Company”) on Form 10-Q for the fiscal period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stanley C. Erck, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:
 
1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the dates and periods covered by this Report.

 
By: 
/s/ Stanley C. Erck
 
President and Chief Executive Officer

Date: May 10, 2011
 
 
 
 

NOVAVAX INC Reports